OLD National Bancorp IN Has $27.54 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

OLD National Bancorp IN reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 54,443 shares of the healthcare conglomerate's stock after selling 1,710 shares during the period. UnitedHealth Group makes up about 0.7% of OLD National Bancorp IN's portfolio, making the stock its 26th biggest holding. OLD National Bancorp IN's holdings in UnitedHealth Group were worth $27,541,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after acquiring an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at approximately $32,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, RPg Family Wealth Advisory LLC acquired a new position in shares of UnitedHealth Group during the third quarter worth $37,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Barclays decreased their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a report on Friday, January 17th. KeyCorp reaffirmed an "overweight" rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Piper Sandler cut their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Buy" and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 0.8 %

NYSE UNH opened at $538.29 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $495.38 billion, a P/E ratio of 34.73, a PEG ratio of 1.41 and a beta of 0.62. The business has a fifty day simple moving average of $539.43 and a 200 day simple moving average of $565.28.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 earnings per share. UnitedHealth Group's quarterly revenue was up 6.8% on a year-over-year basis. On average, analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.56%. UnitedHealth Group's payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.